Globant: Too Cheap To Ignore

73% share price decline after stalled revenue growth and profitability halved; stock now trades at a single-digit PE. 2026 guidance implies revenue growth of just 0.2%–2.2% and lower EPS versus prior double-digit expectations, signaling a stabilization year rather than a return to rapid growth. Management is pivoting aggressively to AI-driven, subscription-based services, but intense competition and limited differentiation risk constraining margin and revenue recovery in the near term.

Analysis

A company transitioning from bespoke professional services to subscription and GenAI IP faces a predictable two-stage cycle: near-term revenue visibility improves only after ARR scale is demonstrable, while margins often compress during the engineering-heavy build phase. Expect compute and partnership economics (cloud credits, revenue share with hyperscalers, ML ops tooling) to become the dominant cost levers — this shifts where financial stress shows up (OpEx and gross margin cadence rather than one-off project slippage).

Competitive dynamics favor firms that can (a) embed proprietary datasets/vertical workflows, (b) secure deep hyperscaler co-sell arrangements, or (c) leverage scale to absorb model inference costs. Mid-sized integrators and boutiques without those moats will see accelerating fee pressure and talent outflows; hyperscalers gain pricing optionality to internalize client spend and compress third-party margins over 6-24 months.

Key tail risks are execution (productizing research into repeatable ARR), hyperscaler bundling, and client-level churn on large accounts — each can crystallize inside a single renewal cycle (~6-12 months). Reversal catalysts are equally binary: multiyear, non-cancellable subscription wins or a strategic go-to-market alliance with a top cloud provider can trigger a rapid re-rating within 3-9 months once revenue recognition rules convert backlog to ARR.

From a capital markets angle the current risk premium likely prices in growth failure rather than optionality; that makes conditional, event-driven structures attractive. However, the payoff is asymmetric — a clean ARR print or major partnership can deliver a 40-80% upside jump, while a multi-quarter miss can continue to de-rate the equity meaningfully over 12 months.

Key Decisions for Investors

• Pair trade (6-12 months): Short GLOB equity vs Long ACN (size 1:1) to isolate execution risk in the mid-market segment. R/R: target 20-30% relative move; stop if GLOB outperforms ACN by 8-10% over any 30-day window.
• Directional hedge (3-6 months): Buy a GLOB put spread (buy near-term ATM put, sell 20-30% OTM put) sized to 1-2% NAV. R/R: limited known downside (premium) with 3:1+ payoff to downside if execution headlines miss next two quarters.
• Long software/scale-exposure (12 months): Buy either EPAM or ACN 12-month call spreads to capture hyperscaler capture and scale advantage (size defensive bucket). R/R: 2:1 asymmetric upside vs downside; use call spreads to cap cost.
• Event-driven optionality: If management announces a multi-year, non-cancellable ARR contract or hyperscaler strategic partnership, pivot to long GLOB via Jan- or 18-month call spreads (sell nearer-term calls to fund). R/R: binary upside of 40-80% on successful proof points within 3-9 months.